109 related articles for article (PubMed ID: 3031537)
1. Neuropeptides and leukotriene release: effect of peptide histidine isoleucine and secretin in platelet activating factor-stimulated rat lung.
Di Marzo V; Tippins JR; Morris HR
Neuropeptides; 1987 Jan; 9(1):51-8. PubMed ID: 3031537
[TBL] [Abstract][Full Text] [Related]
2. Neuropeptides and leukotriene biosynthesis: the effect of calcitonin, peptide histidine valine-42, helodermin, neuropeptide Y and galanin.
Di Marzo V; Tippins JR; Galadari SH; Morris HR
Neuropeptides; 1988; 11(4):169-72. PubMed ID: 2458537
[TBL] [Abstract][Full Text] [Related]
3. The role of cyclic AMP in the inhibition of leukotriene biosynthesis by neuropeptides.
Di Marzo V; Tippins JR; Morris HR
Eur J Pharmacol; 1989 Mar; 162(1):115-21. PubMed ID: 2542050
[TBL] [Abstract][Full Text] [Related]
4. The effect of vasoactive intestinal peptide and calcitonin gene-related peptide on peptidoleukotriene release from platelet activating factor stimulated rat lungs and ionophore stimulated guinea pig lungs.
Di Marzo V; Tippins JR; Morris HR
Biochem Int; 1986 Dec; 13(6):933-42. PubMed ID: 2432897
[TBL] [Abstract][Full Text] [Related]
5. Effect of vasoactive intestinal peptide and calcitonin gene-related peptide on leukotriene release from guinea pig and rat lung.
Tippins JR; Di Marzo V; Morris HR
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():1028-32. PubMed ID: 2823553
[No Abstract] [Full Text] [Related]
6. Bradykinin- and chemotactic peptide fMLP-stimulated leukotriene biosynthesis in rat lungs and its inhibition by vasoactive intestinal peptide.
Di Marzo V; Tippins JR; Morris HR
Biochem Int; 1988 Aug; 17(2):235-42. PubMed ID: 2847737
[TBL] [Abstract][Full Text] [Related]
7. Platelet-activating factor stimulation of peptidoleukotriene release: inhibition by vasoactive polypeptide.
Beaubien BB; Tippins JR; Morris HR
Biochem Biophys Res Commun; 1984 Nov; 125(1):105-8. PubMed ID: 6594998
[TBL] [Abstract][Full Text] [Related]
8. Platelet activating factor-mediated leukotriene biosynthesis in rat lungs: effect of prostaglandins E1 and F1 alpha.
Di Marzo V; Tippins JR; Morris HR
Biochem Biophys Res Commun; 1987 Sep; 147(3):1213-8. PubMed ID: 2822041
[TBL] [Abstract][Full Text] [Related]
9. Preoptic injection of VIP, but not of secretin or PHI, inhibits LH and stimulates prolactin secretion in the ovariectomized rat.
Akema T; Hashimoto R; Kimura F
Brain Res; 1988 Feb; 441(1-2):367-70. PubMed ID: 3359239
[TBL] [Abstract][Full Text] [Related]
10. [D-Phe4]peptide histidine-isoleucinamide ([D-Phe4]PHI), a highly selective vasoactive-intestinal-peptide (VIP) agonist, discriminates VIP-preferring from secretin-preferring receptors in rat pancreatic membranes.
Robberecht P; Coy DH; De Neef P; Camus JC; Cauvin A; Waelbroeck M; Christophe J
Eur J Biochem; 1987 Jun; 165(2):243-9. PubMed ID: 3036504
[TBL] [Abstract][Full Text] [Related]
11. Vasoactive intestinal polypeptide-related peptides modulate tyrosine hydroxylase gene expression in PC12 cells through multiple adenylate cyclase-coupled receptors.
Wessels-Reiker M; Basiboina R; Howlett AC; Strong R
J Neurochem; 1993 Mar; 60(3):1018-29. PubMed ID: 8094740
[TBL] [Abstract][Full Text] [Related]
12. Interaction of peptides related to VIP and secretin with guinea pig pancreatic acini.
Zhou ZC; Gardner JD; Jensen RT
Am J Physiol; 1989 Feb; 256(2 Pt 1):G283-90. PubMed ID: 2465694
[TBL] [Abstract][Full Text] [Related]
13. Interaction of thymic peptide thymosin alpha 1 with VIP receptors in rat intestinal epithelial cells: comparison with PHI and secretin.
Calvo JR; Guerrero JM; Goberna R
Gen Pharmacol; 1989; 20(4):503-5. PubMed ID: 2546855
[TBL] [Abstract][Full Text] [Related]
14. Binding in vitro of vasoactive intestinal peptide on isolated acini of rat parotid glands.
Dehaye JP; Christophe J; Ernst F; Poloczek P; Van Bogaert P
Arch Oral Biol; 1985; 30(11-12):827-32. PubMed ID: 2421696
[TBL] [Abstract][Full Text] [Related]
15. Porcine peptide having N-terminal histidine and C-terminal isoleucine amide (PHI): vasoactive intestinal peptide (VIP) and secretin-like effects in different tissues from the rat.
Bataille D; Gespach C; Laburthe M; Amiranoff B; Tatemoto K; Vauclin N; Mutt V; Rosselin G
FEBS Lett; 1980 Jun; 114(2):240-2. PubMed ID: 6248367
[No Abstract] [Full Text] [Related]
16. Secretin/vasoactive intestinal peptide-stimulated secretion of bombesin/gastrin releasing peptide from human small cell carcinoma of the lung.
Korman LY; Carney DN; Citron ML; Moody TW
Cancer Res; 1986 Mar; 46(3):1214-8. PubMed ID: 3002612
[TBL] [Abstract][Full Text] [Related]
17. Effects of neuropeptides on heart rate in dogs: comparison of VIP, PHI, NPY, CGRP, and NT.
Rigel DF
Am J Physiol; 1988 Aug; 255(2 Pt 2):H311-7. PubMed ID: 3261545
[TBL] [Abstract][Full Text] [Related]
18. Interaction between vasoactive intestinal polypeptide (VIP) and peptide histidine isoleucine (PHI) in stimulating the secretion of prolactin from rat anterior pituitary cells in vitro.
Inoue T; Kato Y; Koshiyama H; Yanaihara N; Imura H
Neurosci Lett; 1988 Mar; 85(3):363-9. PubMed ID: 3362424
[TBL] [Abstract][Full Text] [Related]
19. Prejunctional inhibition of vasoactive intestinal peptide release.
Grider JR; Makhlouf GM
Am J Physiol; 1987 Jul; 253(1 Pt 1):G7-12. PubMed ID: 3605338
[TBL] [Abstract][Full Text] [Related]
20. Metabolism of leukotriene E4 by rat tissues: formation of N-acetyl leukotriene E4.
Bernström K; Hammarström S
Arch Biochem Biophys; 1986 Feb; 244(2):486-91. PubMed ID: 3004344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
